Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$10.8K
4 trades · 2 insiders
Net · 90d
$-10.8K
Insiders on file
23
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Wong Shelly | VP, Finance and CAO | 36 | $0 | $159.1K | 2026-08-17 |
| Lettmann Jason | Director, 10% Owner | 72 | $7.75M | $13.64M | 2026-08-17 |
| Knight Jeff E. | Chief Dev & Operating Officer | 1 | $0 | $0 | 2026-04-16 |
| Klencke Barbara | Director | 4 | $0 | $0 | 2026-04-16 |
| GOODMAN COREY S | Director, 10% Owner | 20 | $21.15M | $0 | 2026-02-02 |
| Shantharam Harish | Chief Financial Officer | 5 | $58.5K | $0 | 2026-01-26 |
| Curran Daniel J. | Director | 2 | $0 | $0 | 2026-01-20 |
| Sandler Alan B. | Director | 5 | $0 | $0 | 2026-01-20 |
| Hemrajani Rekha | Director | 8 | $103.5K | $0 | 2026-01-20 |
| Takimoto Chris H | Director | 2 | $0 | $0 | 2026-01-20 |
| Garland J. Scott | Director | 5 | $0 | $0 | 2026-01-20 |
| Pons Jaume | President and CEO | 78 | $0 | $10.84M | 2025-02-19 |
| Randolph Sophia | Chief Medical Officer | 60 | $0 | $4.64M | 2024-08-14 |
| GARCIA PETER S | Chief Financial Officer | 58 | $261.7K | $6.57M | 2024-08-14 |
| Canamasas Itziar | Director | 3 | $0 | $0 | 2023-06-20 |
| Nielsen Jack | Director, 10% Owner | 4 | $0 | $0 | 2023-06-20 |
| Lightstone Ventures II (A), L.P. | 10% Owner | 12 | $0 | $1.29M | 2021-12-13 |
| LSV Associates II, LLC | 10% Owner | 34 | $7.60M | $4.70M | 2021-12-10 |
| Graham G. Walmsley | Director | 6 | $20.05M | $0 | 2021-06-11 |
| Caffo Nathan | Chief Business Officer | 3 | $0 | $0 | 2020-07-21 |
| venBio Global Strategic GP, Ltd. | 10% Owner | 10 | $16.21M | $0 | 2020-07-21 |
| Vivo Opportunity Fund, L.P. | 10% Owner | 4 | $18.52M | $0 | 2020-07-21 |
| Pietzke Steffen | VP Fin & Chief Acct Officer | 2 | $57.0K | $0 | 2020-07-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Wong Shelly | SVP, FINANCE AND CAO | S Sale | 2026-08-17 | 2026-08-18 | 573 | $1.93 | $1.1K | 87,828 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | S Sale | 2026-08-17 | 2026-08-18 | 2,230 | $1.93 | $4.3K | 294,379 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER, Dir | S Sale | 2026-08-17 | 2026-08-18 | 2,230 | $1.93 | $4.3K | 294,379 | SEC↗ |
| Wong Shelly | SVP, FINANCE AND CAO | S Sale | 2026-08-17 | 2026-08-18 | 573 | $1.93 | $1.1K | 87,828 | SEC↗ |
| Wong Shelly | SVP, FINANCE AND CAO | S Sale | 2026-07-01 | 2026-07-06 | 1,404 | $2.04 | $2.9K | 88,401 | SEC↗ |
| Klencke Barbara | Chief Medical Officer | A Award deriv | 2026-04-16 | 2026-04-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Knight Jeff E. | Chief Dev & Operating Office | A Award deriv | 2026-04-16 | 2026-04-17 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2026-03-19 | 2026-03-23 | 903 | $2.17 | $2.0K | 86,805 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | S Sale | 2026-03-19 | 2026-03-23 | 12,311 | $2.17 | $26.7K | 293,609 | SEC↗ |
| Klencke Barbara | Chief Medical Officer | A Award deriv | 2026-03-03 | 2026-03-05 | 700,000 | — | $0 | 700,000 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2026-02-18 | 2026-02-20 | 565 | $2.27 | $1.3K | 87,708 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2026-02-17 | 2026-02-19 | 2,201 | $2.27 | $5.0K | 305,920 | SEC↗ |
| GOODMAN COREY S | Director, 10% Owner | P Buy | 2026-02-02 | 2026-02-04 | 3,184,713 | $1.57 | $5.00M | 8,453,038 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-01-26 | 2026-01-28 | 912,000 | — | $0 | 912,000 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award deriv | 2026-01-26 | 2026-01-28 | 192,000 | — | $0 | 192,000 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award deriv | 2026-01-26 | 2026-01-28 | 303,000 | — | $0 | 303,000 | SEC↗ |
| Hemrajani Rekha | Director | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Takimoto Chris H | Director | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Curran Daniel J. | Director | A Award deriv | 2026-01-20 | 2026-01-21 | 16,833 | — | $0 | 16,833 | SEC↗ |
| Sandler Alan B. | Director | A Award deriv | 2026-01-20 | 2026-01-21 | 10,100 | — | $0 | 10,100 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| GOODMAN COREY S | Director, 10% Owner | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2026-01-06 | 2026-01-07 | 3,925 | $1.11 | $4.4K | 88,273 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award deriv | 2025-10-14 | 2025-10-16 | 198,750 | — | $0 | 198,750 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-10-14 | 2025-10-16 | 597,500 | — | $0 | 597,500 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award deriv | 2025-10-14 | 2025-10-16 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2025-09-17 | 2025-09-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | P Buy | 2025-09-17 | 2025-09-18 | 71,163 | $1.08 | $76.9K | 305,121 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | P Buy | 2025-09-16 | 2025-09-18 | 21,070 | $1.07 | $22.5K | 233,958 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | P Buy | 2025-08-18 | 2025-08-20 | 75,000 | $0.78 | $58.5K | 75,000 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | S Sale | 2025-08-15 | 2025-08-19 | 2,382 | $0.64 | $1.5K | 212,888 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2025-08-15 | 2025-08-19 | 611 | $0.64 | $391 | 89,198 | SEC↗ |
| Curran Daniel J. | Director | A Award deriv | 2025-08-12 | 2025-08-13 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2025-07-07 | 2025-07-08 | 2,011 | $0.45 | $905 | 86,809 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2025-06-30 | 2025-07-01 | 1,532 | $0.43 | $659 | 88,820 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-04-11 | 2025-04-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award deriv | 2025-04-11 | 2025-04-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Sandler Alan B. | Chief Medical Officer | A Award deriv | 2025-04-11 | 2025-04-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award deriv | 2025-04-11 | 2025-04-15 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award | 2025-03-14 | 2025-03-18 | 42,000 | — | $0 | 212,270 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award | 2025-03-14 | 2025-03-18 | 3,000 | — | $0 | 90,352 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | S Sale | 2025-02-19 | 2025-02-21 | 2,159 | $1.15 | $2.5K | 170,270 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2025-02-19 | 2025-02-21 | 1,326 | $1.15 | $1.5K | 579,388 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2025-02-19 | 2025-02-21 | 550 | $1.15 | $633 | 87,352 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-01-21 | 2025-01-23 | 478,000 | — | $0 | 478,000 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | A Award deriv | 2025-01-21 | 2025-01-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Sandler Alan B. | Chief Medical Officer | A Award deriv | 2025-01-21 | 2025-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award deriv | 2025-01-21 | 2025-01-23 | 112,000 | — | $0 | 112,000 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award deriv | 2025-01-21 | 2025-01-23 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Takimoto Chris H | Director | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| GOODMAN COREY S | Director, 10% Owner | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Hemrajani Rekha | Director | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Pinto Shelly | Interim CFO | S Sale | 2025-01-06 | 2025-01-08 | 2,221 | $1.80 | $4.0K | 87,902 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-12-30 | 2025-01-02 | 10,796 | $1.58 | $17.1K | 580,714 | SEC↗ |
| Pinto Shelly | Interim CFO | S Sale | 2024-12-30 | 2025-01-02 | 1,426 | $1.58 | $2.3K | 90,123 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-12-02 | 2024-12-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Pinto Shelly | Interim CFO | A Award deriv | 2024-12-02 | 2024-12-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Hemrajani Rekha | Director | P Buy | 2024-12-02 | 2024-12-04 | 30,000 | $1.55 | $46.5K | 33,000 | SEC↗ |
| Sandler Alan B. | Chief Medical Officer | A Award deriv | 2024-11-18 | 2024-11-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-08-14 | 2024-08-16 | 2,191 | $2.58 | $5.7K | 169,429 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-08-14 | 2024-08-16 | 1,937 | $2.58 | $5.0K | 591,510 | SEC↗ |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-08-14 | 2024-08-16 | 761 | $2.58 | $2.0K | 121,516 | SEC↗ |
| Randolph Sophia | CHIEF MEDICAL OFFICER | S Sale | 2024-08-14 | 2024-08-16 | 1,365 | $2.58 | $3.5K | 325,711 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2024-08-14 | 2024-08-16 | 564 | $2.58 | $1.5K | 91,549 | SEC↗ |
| Sandler Alan B. | Director | A Award deriv | 2024-08-05 | 2024-08-07 | 40,400 | — | $0 | 40,400 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise deriv | 2024-07-11 | 2024-07-15 | 20,000 | — | $0 | 144,433 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise | 2024-07-11 | 2024-07-15 | 20,000 | $0.99 | $19.8K | 613,447 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-07-11 | 2024-07-15 | 20,000 | $7.90 | $158.0K | 593,447 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2024-07-05 | 2024-07-09 | 1,823 | $5.50 | $10.0K | 92,113 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-07-01 | 2024-07-03 | 10,758 | $5.82 | $62.6K | 593,447 | SEC↗ |
| Randolph Sophia | CHIEF MEDICAL OFFICER | S Sale | 2024-07-01 | 2024-07-03 | 3,273 | $5.82 | $19.0K | 327,076 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | S Sale | 2024-07-01 | 2024-07-03 | 1,373 | $5.82 | $8.0K | 93,936 | SEC↗ |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-06-28 | 2024-07-02 | 1,789 | $6.03 | $10.8K | 122,277 | SEC↗ |
| GOODMAN COREY S | Director, 10% Owner | A Award deriv | 2024-06-13 | 2024-06-14 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Hemrajani Rekha | Director | A Award deriv | 2024-06-13 | 2024-06-14 | 20,200 | — | $0 | 20,200 | SEC↗ |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | P Buy | 2024-06-13 | 2024-06-17 | 12,000 | $8.53 | $102.4K | 122,348 | SEC↗ |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | P Buy | 2024-06-13 | 2024-06-24 | 12,000 | $8.53 | $102.4K | 122,348 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise deriv | 2024-06-04 | 2024-06-06 | 20,000 | — | $0 | 164,433 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-06-04 | 2024-06-06 | 20,000 | $8.43 | $168.6K | 604,205 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise | 2024-06-04 | 2024-06-06 | 20,000 | $0.99 | $19.8K | 624,205 | SEC↗ |
| Randolph Sophia | CHIEF MEDICAL OFFICER | S Sale | 2024-05-13 | 2024-05-15 | 1,797 | $16.67 | $30.0K | 330,349 | SEC↗ |
| Randolph Sophia | CHIEF MEDICAL OFFICER | S Sale | 2024-05-13 | 2024-05-15 | 10,203 | $15.82 | $161.4K | 332,146 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise deriv | 2024-05-06 | 2024-05-08 | 20,000 | — | $0 | 184,433 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-05-06 | 2024-05-08 | 20,000 | $15.92 | $318.4K | 604,205 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise | 2024-05-06 | 2024-05-08 | 20,000 | $0.99 | $19.8K | 624,205 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise deriv | 2024-04-16 | 2024-04-18 | 25,846 | — | $0 | 204,433 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-04-16 | 2024-04-18 | 50,000 | $14.20 | $710.0K | 604,205 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | M Exercise | 2024-04-16 | 2024-04-18 | 25,846 | $0.99 | $25.6K | 654,205 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | S Sale | 2024-04-04 | 2024-04-05 | 20,000 | $11.15 | $223.0K | 628,359 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | P Buy | 2024-03-14 | 2024-03-18 | 4,400 | $11.31 | $49.8K | 171,620 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-02-14 | 2024-02-16 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | A Award deriv | 2024-02-14 | 2024-02-16 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Randolph Sophia | CHIEF MEDICAL OFFICER | A Award deriv | 2024-02-14 | 2024-02-16 | 95,000 | — | $0 | 95,000 | SEC↗ |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-02-14 | 2024-02-16 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award deriv | 2024-02-14 | 2024-02-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | A Award | 2024-02-14 | 2024-02-16 | 60,000 | — | $0 | 167,220 | SEC↗ |
| Pons Jaume | PRESIDENT & CSO | A Award | 2024-02-14 | 2024-02-16 | 30,000 | — | $0 | 648,359 | SEC↗ |
| Randolph Sophia | CHIEF MEDICAL OFFICER | A Award | 2024-02-14 | 2024-02-16 | 30,000 | — | $0 | 342,349 | SEC↗ |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | A Award | 2024-02-14 | 2024-02-16 | 25,000 | — | $0 | 110,348 | SEC↗ |
| Pinto Shelly | SVP, FINANCE AND CAO | A Award | 2024-02-14 | 2024-02-16 | 15,000 | — | $0 | 93,591 | SEC↗ |
| Pinto Shelly | SVP, Finance and CAO | S Sale | 2024-01-04 | 2024-01-05 | 2,717 | $13.60 | $37.0K | 78,591 | SEC↗ |
| Pons Jaume | President & CSO | S Sale | 2023-12-29 | 2024-01-03 | 7,179 | $15.04 | $108.0K | 618,359 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2023-12-29 | 2024-01-03 | 1,893 | $15.04 | $28.5K | 85,348 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2023-12-29 | 2024-01-03 | 3,128 | $15.04 | $47.0K | 312,349 | SEC↗ |
| Pinto Shelly | SVP, Finance and CAO | S Sale | 2023-12-29 | 2024-01-03 | 1,631 | $15.04 | $24.5K | 81,308 | SEC↗ |
| Lettmann Jason | Chief Executive Officer | A Award deriv | 2023-09-08 | 2023-09-12 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| Pons Jaume | President & CEO | A Award deriv | 2023-07-25 | 2023-07-27 | 282,000 | — | $0 | 282,000 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | A Award deriv | 2023-07-25 | 2023-07-27 | 101,000 | — | $0 | 101,000 | SEC↗ |
| Pinto Shelly | SVP, Finance and CAO | A Award deriv | 2023-07-25 | 2023-07-27 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | A Award deriv | 2023-07-25 | 2023-07-27 | 107,000 | — | $0 | 107,000 | SEC↗ |
| Pons Jaume | President & CEO | A Award | 2023-07-25 | 2023-07-27 | 89,000 | — | $0 | 625,538 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | A Award | 2023-07-25 | 2023-07-27 | 32,000 | — | $0 | 86,738 | SEC↗ |
| Pinto Shelly | SVP, Finance and CAO | A Award | 2023-07-25 | 2023-07-27 | 26,000 | — | $0 | 81,713 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | A Award | 2023-07-25 | 2023-07-27 | 34,000 | — | $0 | 315,477 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | S Sale | 2023-07-06 | 2023-07-07 | 7,345 | $6.52 | $47.9K | 55,713 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2023-06-30 | 2023-07-05 | 887 | $7.34 | $6.5K | 54,738 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | S Sale | 2023-06-30 | 2023-07-05 | 466 | $7.34 | $3.4K | 63,058 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2023-06-30 | 2023-07-05 | 3,208 | $7.34 | $23.5K | 536,538 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2023-06-30 | 2023-07-05 | 1,605 | $7.34 | $11.8K | 281,477 | SEC↗ |
| Canamasas Itziar | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 10,100 | — | $0 | 10,100 | SEC↗ |
| GOODMAN COREY S | Director, 10% Owner | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Hemrajani Rekha | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Nielsen Jack | Director, 10% Owner | A Award deriv | 2023-06-20 | 2023-06-22 | 20,200 | — | $0 | 20,200 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2023-06-09 | 2023-06-13 | 2,546 | — | $0 | 92,629 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2023-06-09 | 2023-06-13 | 6,256 | — | $0 | 19,084 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2023-06-09 | 2023-06-13 | 4,027 | — | $0 | 0 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2023-06-09 | 2023-06-13 | 2,546 | $4.08 | $10.4K | 276,826 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2023-06-09 | 2023-06-13 | 6,256 | $4.81 | $30.1K | 283,082 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2023-06-09 | 2023-06-13 | 4,027 | $1.91 | $7.7K | 274,280 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2022-12-29 | 2023-01-03 | 3,232 | $11.07 | $35.8K | 539,746 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2022-12-29 | 2023-01-03 | 893 | $11.07 | $9.9K | 53,723 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2022-12-29 | 2023-01-03 | 1,617 | $11.07 | $17.9K | 270,253 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | S Sale | 2022-12-29 | 2023-01-03 | 482 | $11.07 | $5.3K | 62,097 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2022-12-16 | 2022-12-20 | 8,404 | — | $0 | 4,027 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2022-12-16 | 2022-12-20 | 12,731 | — | $0 | 95,175 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2022-12-16 | 2022-12-20 | 25,339 | — | $0 | 25,340 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2022-12-16 | 2022-12-20 | 12,731 | $4.08 | $51.9K | 246,531 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2022-12-16 | 2022-12-20 | 8,404 | $1.91 | $16.1K | 233,800 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2022-12-16 | 2022-12-20 | 25,339 | $4.81 | $121.9K | 271,870 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2022-11-28 | 2022-11-29 | 24,009 | — | $0 | 24,009 | SEC↗ |
| Pons Jaume | President & CEO | A Award deriv | 2022-08-05 | 2022-08-09 | 244,000 | — | $0 | 244,000 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | A Award deriv | 2022-08-05 | 2022-08-09 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | A Award deriv | 2022-08-05 | 2022-08-09 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | A Award deriv | 2022-08-05 | 2022-08-09 | 123,000 | — | $0 | 123,000 | SEC↗ |
| Pons Jaume | President & CEO | A Award | 2022-08-05 | 2022-08-09 | 74,000 | — | $0 | 542,978 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | A Award | 2022-08-05 | 2022-08-09 | 29,000 | — | $0 | 55,178 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | A Award | 2022-08-05 | 2022-08-09 | 11,000 | — | $0 | 62,718 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | A Award | 2022-08-05 | 2022-08-09 | 37,000 | — | $0 | 225,396 | SEC↗ |
| GOODMAN COREY S | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 12,004 | — | $0 | 12,004 | SEC↗ |
| Hemrajani Rekha | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 12,004 | — | $0 | 12,004 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | A Award deriv | 2022-06-15 | 2022-06-16 | 12,004 | — | $0 | 12,004 | SEC↗ |
| Canamasas Itziar | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 12,004 | — | $0 | 12,004 | SEC↗ |
| Canamasas Itziar | Director | A Award deriv | 2022-04-11 | 2022-04-14 | 24,009 | — | $0 | 24,009 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2022-02-07 | 2022-02-08 | 8,363 | — | $0 | 20,813 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2022-02-07 | 2022-02-08 | 6,637 | — | $0 | 89,022 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2022-02-07 | 2022-02-08 | 6,637 | $4.08 | $27.1K | 16,120 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2022-02-07 | 2022-02-08 | 8,363 | $4.81 | $40.2K | 24,483 | SEC↗ |
| Pons Jaume | President & CEO | M Exercise deriv | 2022-02-03 | 2022-02-07 | 12,254 | — | $0 | 6,128 | SEC↗ |
| Pons Jaume | President & CEO | M Exercise deriv | 2022-02-03 | 2022-02-07 | 11,900 | — | $0 | 230,279 | SEC↗ |
| Pons Jaume | President & CEO | M Exercise | 2022-02-03 | 2022-02-07 | 11,900 | $0.99 | $11.8K | 456,724 | SEC↗ |
| Pons Jaume | President & CEO | M Exercise | 2022-02-03 | 2022-02-07 | 12,254 | $1.91 | $23.4K | 468,978 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | A Award | 2022-01-28 | 2022-02-01 | 50,000 | — | $0 | 50,446 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2021-12-15 | 2021-12-16 | 11,059 | — | $0 | 12,431 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2021-12-15 | 2021-12-16 | 12,793 | — | $0 | 0 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2021-12-15 | 2021-12-16 | 12,793 | $0.99 | $12.7K | 177,337 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2021-12-15 | 2021-12-16 | 11,059 | $1.91 | $21.1K | 188,396 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 2,196 | $28.37 | $62.3K | 2,099,095 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 299 | $28.37 | $8.5K | 286,197 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 1,329 | $29.60 | $39.3K | 2,097,766 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 60 | $30.23 | $1.8K | 285,956 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 1,627 | $25.29 | $41.1K | 290,131 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 440 | $30.23 | $13.3K | 2,097,326 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 1,296 | $27.49 | $35.6K | 286,496 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 9,509 | $27.49 | $261.4K | 2,101,291 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 2,339 | $26.48 | $61.9K | 287,792 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 17,169 | $26.48 | $454.6K | 2,110,800 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 181 | $29.60 | $5.4K | 286,016 | SEC↗ |
| Lightstone Ventures II (A), L. | 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 11,945 | $25.29 | $302.1K | 2,127,969 | SEC↗ |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 2,196 | $28.37 | $62.3K | 2,099,095 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 299 | $28.37 | $8.5K | 286,197 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 1,329 | $29.60 | $39.3K | 2,097,766 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 1,296 | $27.49 | $35.6K | 286,496 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 286,496 | $27.49 | $7.88M | 2,101,291 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 2,339 | $26.48 | $61.9K | 287,792 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 17,169 | $26.48 | $454.6K | 2,110,800 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 1,627 | $25.29 | $41.1K | 290,131 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 11,945 | $25.29 | $302.1K | 2,127,969 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 60 | $30.23 | $1.8K | 285,956 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 181 | $29.60 | $5.4K | 286,016 | SEC↗ | |
| Director, 10% Owner | S Sale | 2021-12-13 | 2021-12-15 | 440 | $30.23 | $13.3K | 2,097,326 | SEC↗ | |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 12 | $32.16 | $386 | 291,758 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 88 | $32.16 | $2.8K | 2,139,914 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 2,172 | $31.55 | $68.5K | 291,770 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 15,942 | $31.55 | $503.0K | 2,140,002 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 967 | $30.77 | $29.8K | 293,942 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 7,093 | $30.77 | $218.3K | 2,155,944 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 12 | $32.16 | $386 | 291,758 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 88 | $32.16 | $2.8K | 2,139,914 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 2,172 | $31.55 | $68.5K | 291,770 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 15,942 | $31.55 | $503.0K | 2,140,002 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 967 | $30.77 | $29.8K | 293,942 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-10 | 2021-12-10 | 7,093 | $30.77 | $218.3K | 2,155,944 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 1,911 | $32.73 | $62.5K | 294,909 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 14,028 | $32.73 | $459.1K | 2,163,037 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 5,751 | $32.06 | $184.4K | 296,820 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 42,203 | $32.06 | $1.35M | 2,177,065 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 1,560 | $31.08 | $48.5K | 302,571 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 11,452 | $31.08 | $355.9K | 2,219,268 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 1,911 | $32.73 | $62.5K | 294,909 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 14,028 | $32.73 | $459.1K | 2,163,037 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 5,751 | $32.06 | $184.4K | 296,820 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 42,203 | $32.06 | $1.35M | 2,177,065 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 1,560 | $31.08 | $48.5K | 302,571 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-09 | 2021-12-10 | 11,452 | $31.08 | $355.9K | 2,219,268 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 35,836 | $33.23 | $1.19M | 2,232,251 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 1,531 | $33.80 | $51.7K | 2,230,720 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 4,883 | $33.23 | $162.3K | 304,339 | SEC↗ |
| LSV Associates II, LLC | 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 208 | $33.80 | $7.0K | 304,131 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 1,531 | $33.80 | $51.7K | 2,230,720 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 208 | $33.80 | $7.0K | 304,131 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 35,836 | $33.23 | $1.19M | 2,232,251 | SEC↗ |
| Lettmann Jason | Director, 10% Owner | S Sale | 2021-12-08 | 2021-12-10 | 4,883 | $33.23 | $162.3K | 304,339 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise deriv | 2021-11-22 | 2021-11-23 | 30,000 | — | $0 | 107,906 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-11-22 | 2021-11-23 | 14,884 | $36.77 | $547.3K | 164,544 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | M Exercise | 2021-11-22 | 2021-11-23 | 30,000 | $4.08 | $122.4K | 179,428 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-10-19 | 2021-10-20 | 2,229 | $55.12 | $122.9K | 444,598 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-10-19 | 2021-10-20 | 14,471 | $54.17 | $783.9K | 446,827 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-10-19 | 2021-10-20 | 2,229 | $55.12 | $122.9K | 444,598 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-10-19 | 2021-10-20 | 14,471 | $54.17 | $783.9K | 446,827 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2021-10-18 | 2021-10-19 | 7,229 | — | $0 | 60,468 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-10-18 | 2021-10-19 | 2,851 | $54.33 | $154.9K | 13,709 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2021-10-18 | 2021-10-19 | 7,229 | $4.08 | $29.5K | 16,560 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-10-18 | 2021-10-19 | 189 | $59.06 | $11.2K | 9,331 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-10-18 | 2021-10-19 | 1,903 | $55.15 | $105.0K | 11,806 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-10-18 | 2021-10-19 | 438 | $58.30 | $25.5K | 9,520 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-10-18 | 2021-10-19 | 411 | $57.54 | $23.6K | 9,958 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-10-18 | 2021-10-19 | 1,437 | $56.09 | $80.6K | 10,369 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-10-11 | 2021-10-12 | 4,948 | $60.79 | $300.8K | 151,867 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-10-11 | 2021-10-12 | 2,439 | $61.36 | $149.7K | 149,428 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-09-20 | 2021-09-21 | 10,322 | $74.42 | $768.2K | 463,247 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-09-20 | 2021-09-21 | 1,714 | $75.46 | $129.3K | 461,533 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-09-20 | 2021-09-21 | 235 | $76.46 | $18.0K | 461,298 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-09-20 | 2021-09-21 | 4,429 | $73.78 | $326.8K | 473,569 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2021-09-17 | 2021-09-17 | 11,345 | — | $0 | 67,697 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-09-17 | 2021-09-17 | 1,027 | $77.84 | $79.9K | 19,649 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-09-17 | 2021-09-17 | 273 | $80.22 | $21.9K | 10,431 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-09-17 | 2021-09-17 | 1,746 | $79.46 | $138.7K | 10,704 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-09-17 | 2021-09-17 | 7,199 | $78.61 | $565.9K | 12,450 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-09-17 | 2021-09-17 | 1,100 | $81.19 | $89.3K | 9,331 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2021-09-17 | 2021-09-17 | 11,345 | $4.08 | $46.3K | 20,676 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2021-09-16 | 2021-09-17 | 1,426 | — | $0 | 79,042 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-09-16 | 2021-09-17 | 1,426 | $80.43 | $114.7K | 9,331 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2021-09-16 | 2021-09-17 | 1,426 | $4.08 | $5.8K | 10,757 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-09-10 | 2021-09-13 | 5,029 | $77.69 | $390.7K | 158,273 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-09-10 | 2021-09-13 | 1,458 | $78.31 | $114.2K | 156,815 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-09-10 | 2021-09-13 | 900 | $76.45 | $68.8K | 163,302 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2021-08-23 | 2021-08-24 | 19,370 | — | $0 | 80,468 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2021-08-23 | 2021-08-24 | 40,630 | — | $0 | 95,659 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 10,743 | $75.71 | $813.4K | 11,982 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 19,448 | $75.09 | $1.46M | 22,725 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 4,008 | $73.57 | $294.9K | 42,173 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 18,060 | $72.66 | $1.31M | 46,181 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 35 | $77.56 | $2.7K | 9,331 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 1,593 | $70.86 | $112.9K | 67,738 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2021-08-23 | 2021-08-24 | 60,000 | $4.08 | $244.8K | 69,331 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 2,616 | $76.66 | $200.5K | 9,366 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-23 | 2021-08-24 | 3,497 | $72.03 | $251.9K | 64,241 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 617 | $66.24 | $40.9K | 477,998 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 4,007 | $60.78 | $243.5K | 483,058 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 556 | $64.22 | $35.7K | 479,988 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 1,190 | $62.84 | $74.8K | 480,544 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 1,324 | $61.91 | $82.0K | 481,734 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 7,633 | $59.79 | $456.4K | 487,065 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-08-19 | 2021-08-20 | 1,373 | $65.60 | $90.1K | 478,615 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise deriv | 2021-08-17 | 2021-08-18 | 10,000 | — | $0 | 136,289 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-17 | 2021-08-18 | 2,368 | $65.83 | $155.9K | 12,276 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-17 | 2021-08-18 | 2,400 | $68.34 | $164.0K | 9,371 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-17 | 2021-08-18 | 505 | $67.13 | $33.9K | 11,771 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-17 | 2021-08-18 | 40 | $68.62 | $2.7K | 9,331 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | S Sale | 2021-08-17 | 2021-08-18 | 4,687 | $65.24 | $305.8K | 14,644 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | M Exercise | 2021-08-17 | 2021-08-18 | 10,000 | $4.08 | $40.8K | 19,331 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-08-10 | 2021-08-11 | 5,599 | $64.76 | $362.6K | 164,272 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-08-10 | 2021-08-11 | 70 | $65.46 | $4.6K | 164,202 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-08-10 | 2021-08-11 | 1,718 | $64.20 | $110.3K | 169,871 | SEC↗ |
| Pons Jaume | President & CEO | A Award deriv | 2021-07-30 | 2021-08-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| GARCIA PETER S | Chief Financial Officer | A Award deriv | 2021-07-30 | 2021-08-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | A Award deriv | 2021-07-30 | 2021-08-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Pinto Shelly | VP, Finance and CAO | A Award deriv | 2021-07-30 | 2021-08-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-07-19 | 2021-07-20 | 9,500 | $54.37 | $516.5K | 500,446 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-07-19 | 2021-07-20 | 5,900 | $55.08 | $325.0K | 494,546 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-07-19 | 2021-07-20 | 1,300 | $53.62 | $69.7K | 509,946 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-07-12 | 2021-07-14 | 7,087 | $54.86 | $388.8K | 171,889 | SEC↗ |
| Randolph Sophia | Chief Medical Officer | S Sale | 2021-07-12 | 2021-07-14 | 300 | $55.86 | $16.8K | 171,589 | SEC↗ |
| Pons Jaume | President & CEO | S Sale | 2021-06-21 | 2021-06-22 | 6,347 | $58.06 | $368.5K | 521,599 | SEC↗ |